Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neighbourly Pharmacy Inc T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or Rubicon Pharmacies. The Company owns and operates approximately 287 locations across seven provinces and one territory, a coast-to-coast footprint that provides scale and diversification. The Company’s pharmacies provide accessible healthcare with a personal touch. The Company also owns British Columbia-based pharmacies.


TSX:NBLY - Post by User

Post by retiredcfon Aug 09, 2022 10:14am
151 Views
Post# 34881299

Assessment

Assessment

Would appreciate your view of their latest quarterly. Am in for long term, 5 years plus, but currently underwater by 15%. Appropriate to increase holding or hold tight??

For the first quarter, NBLY reported same-store sales growth of 1.8%. Revenue increased 34% year-over-year to $114.4 million, missing estimates of $115.2 million. The growth was driven by acquisitions of pharmacies over the past year. NBLY reported a narrower net loss of $743,000 or $0.03 per share vs a net loss of $76.9 million or $7.50 per share in the first quarter of 2021. Adjusted EPS of $0.09 came in ahead of $0.07 reported a year ago, beating estimates of $0.03. The quarter reported showed margin pressures were evident due to labour issues. NBLY is seeing headwinds with the labour situation and we might give the negative momentum time to settle in if/before adding but don't think much changes here longer-term. (5iResearch)


<< Previous
Bullboard Posts
Next >>